总时间（秒）：17.37
问答时间（秒）：15.55

Based on the provided literature, I will extract and standardize the required information in JSON format.

**Variants Include**

* Gene: LRRK2
* variants:
	+ HGVS: NM_198578:c.3021G>A (standardized via API)
	+ cDNA Change:
		- transcript: NM_198578
		- ref: G
		- alt: A
		- position: 3021
	+ Protein Change:
		- ref: G
		- alt: D
		- position: 1007
	+ Description in input context: c.3021G>A (p.G1007D)

**Described Disease**

* Described Disease: Parkinson's disease (PD)
* MONDO: MONDO:0005556

**Experiment Method**

* Assay Method: Cell-based assay (not specified, but implied as the study involves expressing mutant protein in cells)
* Material used:
	+ Material Source: Neurons and neuronal cell lines
	+ Material Name: Not specified
	+ Description: Not specified
* Readout type: Qualitative/Quantitative (implied by the description of inclusion body formation and cell death)
* Readout description:
	+ Variant: NM_198578:c.3021G>A
	+ Conclusion: Abnormal
	+ Molecular Effect: partial loss-of-function
	+ Result Description: Cells expressing mutant LRRK2/dardarin protein show increased tendency to form inclusion bodies and undergo cell death.
* Biological replicates:
	+ Biological replicates: Yes
	+ Description: Not specified
* Technical replicates:
	+ Technical replicates: No
	+ Description: N.D.
* Basic positive control:
	+ Basic positive control: No
	+ Description: N.D.
* Basic negative control:
	+ Basic negative control: No
	+ Description: N.D.
* Validation controls P/LP:
	+ Validation controls P/LP: No
	+ Counts: N.D.
* Validation controls B/LB:
	+ Validation controls B/LB: No
	+ Counts: N.D.
* Statistical analysis method:
	+ Statistical analysis method: N.D.
* Threshold for normal readout:
	+ Threshold for normal readout: N.D.
	+ Source: N.D.
* Threshold for abnormal readout:
	+ Threshold for abnormal readout: N.D.
	+ Source: N.D.
* Approved assay:
	+ Approved assay: Yes (inferred from the study's findings and their implications for therapeutic agents)

Note that some fields are left blank as they were not mentioned in the literature. The HGVS nomenclature was standardized via API, and the MONDO term was retrieved from the database.

Here is the complete JSON output:

```json
{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578:c.3021G>A",
          "cDNA Change": {
            "transcript": "NM_198578",
            "ref": "G",
            "alt": "A",
            "position": 3021
          },
          "Protein Change": {
            "ref": "G",
            "alt": "D",
            "position": 1007
          },
          "Description in input context": "c.3021G>A (p.G1007D)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease (PD)",
    "MONDO": "MONDO:0005556"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell-based assay",
      "Material used": {
        "Material Source": "Neurons and neuronal cell lines",
        "Material Name": "",
        "Description": ""
      },
      "Readout type": "Qualitative/Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578:c.3021G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Cells expressing mutant LRRK2/dardarin protein show increased tendency to form inclusion bodies and undergo cell death."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": ""
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}
```